Molina Healthcare, Inc. MOH
We take great care to ensure that the data presented and summarized in this overview for MOLINA HEALTHCARE, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MOH
View all-
Vanguard Group Inc Valley Forge, PA6.44MShares$885 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.19MShares$714 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA5.17MShares$711 Million0.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.5MShares$482 Million0.07% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.93MShares$404 Million0.37% of portfolio
-
Harris Associates L P Chicago, IL2.68MShares$369 Million0.85% of portfolio
-
State Street Corp Boston, MA2.41MShares$332 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.97MShares$271 Million0.23% of portfolio
-
Geode Capital Management, LLC Boston, MA1.56MShares$214 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA1.36MShares$187 Million0.04% of portfolio
Latest Institutional Activity in MOH
Top Purchases
Top Sells
About MOH
Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Insider Transactions at MOH
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2025
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
357
-3.05%
|
$51,051
$143.02 P/Share
|
|
Oct 01
2025
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
285
+1.61%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
285
+2.38%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Indirect |
285
+1.91%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
285
+3.6%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
285
+5.54%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Leo P Grohowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
285
+32.83%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
285
+7.68%
|
$54,720
$192.79 P/Share
|
|
Oct 01
2025
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
285
+1.65%
|
$54,720
$192.79 P/Share
|
|
Aug 06
2025
|
Ronna Romney Director |
SELL
Open market or private sale
|
Indirect |
700
-3.93%
|
$107,100
$153.74 P/Share
|
|
Aug 04
2025
|
James Woys Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+6.5%
|
$1,550,000
$155.97 P/Share
|
|
Jul 01
2025
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+1.55%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Indirect |
180
+1.24%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
180
+2.39%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+3.79%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Leo P Grohowski Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+37.66%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
180
+5.42%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
180
+1.06%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
180
+1.0%
|
$55,080
$306.29 P/Share
|
|
Jul 01
2025
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
183
-1.4%
|
$55,998
$306.29 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 132K shares |
|---|---|
| Open market or private purchase | 10K shares |
| Payment of exercise price or tax liability | 51.9K shares |
|---|---|
| Open market or private sale | 92.7K shares |